DV
Dividend Vision

OLMA — Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc. (OLMA)

Total return is -78.3% over the past 5.7 years, 213.0 points behind SPY at 134.7%. Its deepest 1-year drawdown was 74.4%.

OLMA is a healthcare equity stock that focuses on pharmaceutical development. As a single-stock holding rather than a diversified ETF fund, it does not have a distribution rate, expense ratio, or standard ETF characteristics. The security may appeal to investors seeking exposure to the biotechnology and pharmaceutical sector, though it carries company-specific risk rather than the diversification typical of traditional ETFs.

OLMA key facts

Asset type
Stock
Asset class
Equity
Inception date
11/19/2020
Distribution frequency
None
Last close
$10.63
Market cap
$930,099,584
Average volume
1163100.0
Beta
2.009
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.14